Adrian J Dunlop
Datos Biográficos
| ID | 5561682 |
|---|---|
| NOMBRE | Adrian J Dunlop |
| NOMBRES | Adrian J |
| APELLIDO | Dunlop |
| FIRMA | DUNLOP A J |
| AFILIACIONES | Hunter New England Local Health District |
| ORCID | 0000-0003-2394-5966 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 47 |
| TOTAL DE CITAS | 4 |
| TOTAL COMO AUTOR | 47 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2011 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 1 |
“Probably one of medicine’s best kept secrets”
BACKGROUND: Substance dependence is a significant health problem and major cause of preventable disease worldwide. Addiction Medicine (AM) specialists play an important role across numerous countries in the management and treatment of individuals with problematic substance use. However, there is currently a shortage of Fellows of the Australasian Chapter of Addiction Medicine (AChAM), with many reaching retirement age. This study aimed to inform …
Expanding Access to Addiction Medicine Specialist Care in Regional New South Wales, Australia Through Telehealth
Risk Factors for Cognitive Impairment in Adults Attending Australian Community‐Based Substance Use Treatment Services
Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use
The high HCV reinfection incidence in prisons emphasises the need to enhance prison-based harm reduction measures including access to sterile injecting equipment, currently prohibited in Australian prisons. The finding that reinfection accounts for most recurrent viremia could assist retreatment clinical decision-making in prison
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Aus…
Hydromorphone Hopes
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment
Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
Vaping to quit smoking
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs
Integrating financial incentives into routine service delivery may be an effective strategy to increase clinic attendance and HCV testing among PWID. Further research is needed on optimising financial incentives for HCV treatment initiation
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Bridging the evidence and the politics
Supervised Injectable Opioid Treatment (SIOT) targets people experiencing opioid dependence who have not benefited from existing treatments. In this population, SIOT has been demonstrated to be efficacious and effective, yet this modality of treatment has only been taken up in a few countries. In this commentary we describe the socio-political context and history to the recent establishment of an implementation trial of injectable hydromorphone i…
Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia
A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia
Participant experiences in a pilot study for methamphetamine withdrawal treatment
The experiences of participants in this clinical trial can be distilled into four meta-themes: agency, caring-trust, safety, and communication. Participants spontaneously linked these experiences with a capacity to remain enrolled in the study. By considering the experiences of trial participants in clinical trial design, researchers can improve the experiences of future trial participants and facilitate their choice to remain enrolled in clinica…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Week Retention in Treatment With Extended-Release Subcutaneous Buprenorphine Depot Injections Among People With Opioid Dependence
Indivior
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374196, ACTRN1261800056224
Health and correctional staff acceptability of depot buprenorphine in NSW prisons
The introduction of depot buprenorphine into correctional settings was considered to have the potential to increase safety for patients, improve staff / patient relations and advance patient health outcomes via expanded treatment coverage and efficiencies gained through enhanced health service delivery. Support was almost universal from both correctional and health staff participating in this study. These findings build on emerging research regar…
Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions
Predictors of alcohol use during pregnancy in Australian women
Age at first alcohol‐related hospital separation or emergency department presentation and rate of re‐admission
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Evaluation of early relational disturbance in high‐risk populations
Despite the longstanding theoretical association in the attachment literature between maternal trauma history and disturbances in the mother–infant interaction, few studies have investigated mechanisms of transmission of traumatogenic relational patterns in high‐risk mother–infant dyads. This study investigated interrelationships among maternal trauma history, distorted maternal representations (DMRs, i.e. disturbed thoughts and feelings about th…
Rhetoric, reality and research
New narratives, new selves
Within the expansive qualitative literature on alcohol and other drug (AOD) use, knowledge of lived experiences of AOD addiction is limited. Much of the existing scholarship reifies addiction as a calamitous state, and pathologises those believed to be experiencing it. Such research discounts the many ways people live with regular AOD use and is unable to tell us much about how addiction emerges through, rather than precedes, people’s experiences…
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug us…
Alcohol Text Messages
Risky paternal alcohol use is associated with maternal alcohol use during pregnancy, poor fetal and infant outcomes, domestic violence and depression. This study developed 30 SMS text messages about alcohol for fathers who drink at risky levels . The text messages were developed using two motivational styles: messages presented in a second person voice and the same messages presented in a child's voice. Fifty-one fathers were recruited through so…
Tobacco smoking policies in Australian alcohol and other drug treatment services, agreement between staff awareness and the written policy document
Tobacco smoking within Australian AOD services is mostly regulated by a written policy document. Staff policy awareness was modest and perceived policy enforcement was poor
Addiction stigma and the biopolitics of liberal modernity
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Challenges in maintaining treatment services for people who use drugs during the Covid-19 pandemic
The impact of COVID-19 across health services, including treatment services for people who use drugs, is emerging but likely to have a high impact. Treatment services for people who use drugs provide essential treatment services including opiate agonist treatment and needle syringe programmes alongside other important treatment programmes across all substance types including withdrawal and counselling services. Drug and alcohol hospital consultat…
Substance use treatment clinician attitudes to care for chronic disease health risk behaviours and associations of attitudes with care provision
Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non‐Indigenous people who have recently used methamphetamine
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence
Intensive Behavioural and Pharmacological Treatment for Tobacco Dependence in Pregnant Women with Complex Psychosocial Challenges
Up to 95% of women who use other substances also smoke tobacco during pregnancy. Challenging psychosocial circumstances and other barriers that contribute to high levels of tobacco dependence result in few quitting successfully. This case report describes the treatment of a highly tobacco dependent 34-year-old pregnant woman with a history of recent substance use, mental illness and trauma, enrolled in the Incentives to Quit Tobacco in Pregnancy …
Evaluation of early relational disturbance in high‐risk populations
Despite the longstanding theoretical association in the attachment literature between maternal trauma history and disturbances in the mother–infant interaction, few studies have investigated mechanisms of transmission of traumatogenic relational patterns in high‐risk mother–infant dyads. This study investigated interrelationships among maternal trauma history, distorted maternal representations (DMRs, i.e. disturbed thoughts and feelings about th…
Alcohol and other drug health‐care providers and their client's perceptions of e‐cigarette use, safety and harm reduction
Covid ‐19 vaccination among people who inject drugs
Timely rollout and widespread uptake of safe and effective vaccines will be necessary to reduce mortality, improve health outcomes, restore societal well-being and inspire economic recovery from the coronavirus disease (COVID-19) pandemic. Unprecedented efforts to accelerate vaccine development have resulted in the emergency or expedited approval of several COVID-19 vaccines [1]. The Australian Government has secured access to both the Pfizer and…
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions
Predictors of alcohol use during pregnancy in Australian women
Age at first alcohol‐related hospital separation or emergency department presentation and rate of re‐admission
Medicine (39 obras) · Substance Abuse Treatment and Outcomes (26 obras) · Psychiatry (25 obras) · HIV, Drug Use, Sexual Risk (21 obras) · Opioid Use Disorder Treatment (17 obras) · Internal Medicine (16 obras) · Psychology (15 obras) · Nursing (14 obras) · Family medicine (13 obras) · Hepatitis C virus research (11 obras)